The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Thrush-Global Market Insights and Sales Trends 2024
Synopsis
Oral thrush occurs when a yeast infection develops on the inside of mouth and on tongue. This condition is also known as oral candidiasis, oropharyngeal candidiasis, or, simply, thrush. The Candida albicans fungus causes oral thrush. A small amount of this fungus normally lives in your mouth without causing harm. However, when the fungus begins to grow uncontrollably, an infection can develop in mouth. Oral thrush most often occurs in infants and toddlers. It causes white bumps to form on the inner cheeks and tongue. These growths usually go away once treatment is received.
The global Oral Thrush market size is expected to reach US$ 8819.4 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Thrush in various end use industries. The expanding demands from the Hospitals & Clinics and Academic And Research Institutes, are propelling Oral Thrush market. Pseudomembranous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythematous segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Thrush, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Thrush market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Thrush market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Thrush sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Thrush covered in this report include Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy Laboratories, Bristol Laboratories, Glenmark Pharmaceuticals and GlaxoSmithKline, etc.
The global Oral Thrush market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Teva Pharmaceuticals
Stellar Pharma
Pfizer
Wockhardt
Ranbaxy Laboratories
Bristol Laboratories
Glenmark Pharmaceuticals
GlaxoSmithKline
Global Oral Thrush market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Thrush market, Segment by Type:
Pseudomembranous
Erythematous
Hyperplastic
Global Oral Thrush market, by Application
Hospitals & Clinics
Academic And Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Thrush companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Oral thrush occurs when a yeast infection develops on the inside of mouth and on tongue. This condition is also known as oral candidiasis, oropharyngeal candidiasis, or, simply, thrush. The Candida albicans fungus causes oral thrush. A small amount of this fungus normally lives in your mouth without causing harm. However, when the fungus begins to grow uncontrollably, an infection can develop in mouth. Oral thrush most often occurs in infants and toddlers. It causes white bumps to form on the inner cheeks and tongue. These growths usually go away once treatment is received.
The global Oral Thrush market size is expected to reach US$ 8819.4 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Thrush in various end use industries. The expanding demands from the Hospitals & Clinics and Academic And Research Institutes, are propelling Oral Thrush market. Pseudomembranous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythematous segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Thrush, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Thrush market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Thrush market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Thrush sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Thrush covered in this report include Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy Laboratories, Bristol Laboratories, Glenmark Pharmaceuticals and GlaxoSmithKline, etc.
The global Oral Thrush market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Teva Pharmaceuticals
Stellar Pharma
Pfizer
Wockhardt
Ranbaxy Laboratories
Bristol Laboratories
Glenmark Pharmaceuticals
GlaxoSmithKline
Global Oral Thrush market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Thrush market, Segment by Type:
Pseudomembranous
Erythematous
Hyperplastic
Global Oral Thrush market, by Application
Hospitals & Clinics
Academic And Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Thrush companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Oral Thrush
1.1 Oral Thrush Market Overview
1.1.1 Oral Thrush Product Scope
1.1.2 Oral Thrush Market Status and Outlook
1.2 Global Oral Thrush Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oral Thrush Market Size by Region (2018-2029)
1.4 Global Oral Thrush Historic Market Size by Region (2018-2023)
1.5 Global Oral Thrush Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oral Thrush Market Size (2018-2029)
1.6.1 North America Oral Thrush Market Size (2018-2029)
1.6.2 Europe Oral Thrush Market Size (2018-2029)
1.6.3 Asia-Pacific Oral Thrush Market Size (2018-2029)
1.6.4 Latin America Oral Thrush Market Size (2018-2029)
1.6.5 Middle East & Africa Oral Thrush Market Size (2018-2029)
2 Oral Thrush Market by Type
2.1 Introduction
2.1.1 Pseudomembranous
2.1.2 Erythematous
2.1.3 Hyperplastic
2.2 Global Oral Thrush Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oral Thrush Historic Market Size by Type (2018-2023)
2.2.2 Global Oral Thrush Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oral Thrush Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oral Thrush Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oral Thrush Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oral Thrush Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oral Thrush Revenue Breakdown by Type (2018-2029)
3 Oral Thrush Market Overview by Application
3.1 Introduction
3.1.1 Hospitals & Clinics
3.1.2 Academic And Research Institutes
3.2 Global Oral Thrush Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oral Thrush Historic Market Size by Application (2018-2023)
3.2.2 Global Oral Thrush Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oral Thrush Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oral Thrush Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oral Thrush Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oral Thrush Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oral Thrush Revenue Breakdown by Application (2018-2029)
4 Oral Thrush Competition Analysis by Players
4.1 Global Oral Thrush Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Thrush as of 2022)
4.3 Date of Key Players Enter into Oral Thrush Market
4.4 Global Top Players Oral Thrush Headquarters and Area Served
4.5 Key Players Oral Thrush Product Solution and Service
4.6 Competitive Status
4.6.1 Oral Thrush Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Oral Thrush Products, Services and Solutions
5.1.4 Bayer Oral Thrush Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 Teva Pharmaceuticals
5.2.1 Teva Pharmaceuticals Profile
5.2.2 Teva Pharmaceuticals Main Business
5.2.3 Teva Pharmaceuticals Oral Thrush Products, Services and Solutions
5.2.4 Teva Pharmaceuticals Oral Thrush Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceuticals Recent Developments
5.3 Stellar Pharma
5.3.1 Stellar Pharma Profile
5.3.2 Stellar Pharma Main Business
5.3.3 Stellar Pharma Oral Thrush Products, Services and Solutions
5.3.4 Stellar Pharma Oral Thrush Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Oral Thrush Products, Services and Solutions
5.4.4 Pfizer Oral Thrush Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Wockhardt
5.5.1 Wockhardt Profile
5.5.2 Wockhardt Main Business
5.5.3 Wockhardt Oral Thrush Products, Services and Solutions
5.5.4 Wockhardt Oral Thrush Revenue (US$ Million) & (2018-2023)
5.5.5 Wockhardt Recent Developments
5.6 Ranbaxy Laboratories
5.6.1 Ranbaxy Laboratories Profile
5.6.2 Ranbaxy Laboratories Main Business
5.6.3 Ranbaxy Laboratories Oral Thrush Products, Services and Solutions
5.6.4 Ranbaxy Laboratories Oral Thrush Revenue (US$ Million) & (2018-2023)
5.6.5 Ranbaxy Laboratories Recent Developments
5.7 Bristol Laboratories
5.7.1 Bristol Laboratories Profile
5.7.2 Bristol Laboratories Main Business
5.7.3 Bristol Laboratories Oral Thrush Products, Services and Solutions
5.7.4 Bristol Laboratories Oral Thrush Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol Laboratories Recent Developments
5.8 Glenmark Pharmaceuticals
5.8.1 Glenmark Pharmaceuticals Profile
5.8.2 Glenmark Pharmaceuticals Main Business
5.8.3 Glenmark Pharmaceuticals Oral Thrush Products, Services and Solutions
5.8.4 Glenmark Pharmaceuticals Oral Thrush Revenue (US$ Million) & (2018-2023)
5.8.5 Glenmark Pharmaceuticals Recent Developments
5.9 GlaxoSmithKline
5.9.1 GlaxoSmithKline Profile
5.9.2 GlaxoSmithKline Main Business
5.9.3 GlaxoSmithKline Oral Thrush Products, Services and Solutions
5.9.4 GlaxoSmithKline Oral Thrush Revenue (US$ Million) & (2018-2023)
5.9.5 GlaxoSmithKline Recent Developments
6 North America
6.1 North America Oral Thrush Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oral Thrush Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oral Thrush Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oral Thrush Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oral Thrush Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oral Thrush Market Dynamics
11.1 Oral Thrush Industry Trends
11.2 Oral Thrush Market Drivers
11.3 Oral Thrush Market Challenges
11.4 Oral Thrush Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
